Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$9.77 - $15.33 $246,204 - $386,316
-25,200 Closed
0 $0
Q4 2020

Feb 02, 2021

SELL
$7.41 - $12.63 $18,302 - $31,196
-2,470 Reduced 8.93%
25,200 $290,000
Q2 2020

Aug 12, 2020

BUY
$9.02 - $15.12 $144,320 - $241,920
16,000 Added 137.1%
27,670 $305,000
Q4 2019

Jan 27, 2020

BUY
$13.08 - $17.43 $152,643 - $203,408
11,670 New
11,670 $185,000

Others Institutions Holding VRCA

About Verrica Pharmaceuticals Inc.


  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.